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用下，将 1ml 内水相用匀速注入溶解有 0.025g/ml PDLLA 和 1.0％Span80 的 10ml
外油相中形成 W1/O 初乳液，再将 W1/O 初乳液匀速注入超声波(200W•10S•8 次)
作用下的 100ml 含有 1.0%吐温 80 乳化剂的外水相中形成 W1/O/W2 复乳液，将
















分布于三个峰，其中 19.5% 的微泡平均粒径为 238.1nm，34.3%的微泡平均粒径
为 1.713μm，另外的 46.2%微泡平均粒径为 3.961μm。 
(2) 超声初乳化结合 SPG 微膜乳化法较理想的制备流程及参数为：超声波
（80W•10S•10 次）作用下将 1ml 内水相匀速注入溶解有 0.025g/ml PDLLA 和 1.0
％Span80 的 10ml 外油相中形成 W1/O 初乳液后将初乳液转入 SPG 微膜乳化器压
力舱中，选择 1.1µm 孔径 SPG 膜并调节高纯氮气压力为 50kpa，将此初乳液压
过 SPG 微膜进入 1.0%PVA 分散液中获得稳定的 W1/O/W2 复乳，40℃恒温持续
100rpm/min 低速磁力搅拌过夜，3000g 离心 10min，收集微泡沉淀。该法制备的
微泡除了其中 6.4%平均粒径为 274nm 外，其余 93.6%的微泡平均粒径为
4.124μm，均匀度上明显好于超声乳化法制备的微泡。 
2. 在非载药 PLA 微泡制备研究的基础上，以超声初乳化结合 SPG 微膜乳化
法为载羟基喜树碱 PLA 微泡造影剂制备方法，以不同浓度的羟基喜树碱氢氧化
钠弱碱溶液为内水相，含 1.0%PVA 的 pH6.0 稀盐酸水溶液为外水相，研究不同
的内水相药物浓度对微泡载药率及包封率的影响结果表明，当内水相药物浓度达
到 4mg/ml 时，制备的微泡载药率达到 高值 1.08%，制备的微泡包封率 高值
66.48%。扫描电子显微镜观察发现，所制备的载药微泡的平均粒径在 5μm 左右，
表面光滑圆整。 
3. 载药微泡的体外释药实验发现，在 37℃，100 rpm/min 条件下恒温振荡一






























































Cancer is one of chief diseases to threat the health of human being. Chemical 
therapy is an important method to treat it comparing with operation and radial therapy. 
Hydroxycamptothecin（HCPT） is an antitumor drug that has been used to treat a wide 
range of cancers. And the main medicament of HCPT is lyophilized power and has 
severe side effect. Polylactic acid (PLA) is under extensive research because of its 
unique and excellent biocompatibility and biodegradability, particularly in biomedical 
field. To solve the shortcoming of clinic medicament, we develop a novel medicament 
of PLA microbubble ultrasonic contrast agents loaded HCPT as targeting drug 
delivery systems. 
Ultrasonic locating and targeting microbubble Ultrasonic Contrast Agents (UCA) 
loaded drug is a kind of Targeting Drug Delivery System (TDDS) to release drug 
under the ultrasonic physical effect. The shells of microbubbles are made from 
biodegradable high molecular polymer and the microbubbles are prepared using 
ultrasonic emulsification method with SPG membrane emulsification technique and 
freeze-dry technique. The interior of microbubbles are filled with C3F8 gas. Reflection 
and scattering phenomenon is going to take place when the microbubbles are 
irradiated by ultrasonic, so we can see the image of them on the screen and locate 
them in vivo. Gas in the microbubbles will expand and contract periodically under 
ultrasonic influence, at last the microbubbles will burst and release drug in the area 
that irradiated by ultrasonic. Ultrasonic locating and targeting drug microbubbles 
could increase the drug concentration in targeting area and reduce the blood 
concentration, it is helpful to increase therapy effect and decrease adverse reaction. It 
is a novel physical targeting drug system and it will play a good part in thrombus and 
tumor therapy. 
In this paper, we use PLA as the drug carrier, HCPT as the model drug, and we 
study the preparation of microbubble ultrasonic contrast agents loaded model drug by 
combining ultrasonic emulsification method and SPG membrane emulsification 















1. Preparation of PLA microbubble UCA by ultrasonic W/O/W double emulsion 
method and ultrasonic emulsion method with SPG membrane emulsification 
technique. As the result, by both of them we prepared good uniform-sized 
microbubble UCA, and ultrasonic emulsion method with SPG membrane 
emulsification technique is better than ultrasonic W/O/W double emulsion method. 
(1)We got the better preparation process and parameters by ultrasonic W/O/W 
double emulsion method: 1ml inner aqueous phase (W1) was injected into 10ml outer 
oil phase (O) which contained 0.025g/ml PDLLA and 1.0％Span80 insonated by 
ultrasonic (80W•10S•10times), we got W1/O emulsion. Then the W1/O emulsion was 
injected into 100ml outer aqueous phase (W2) which contained 1.0% Tween80 
insonated by ultrasonic (200W•10S•8times),so we got W1/O/W2 double emulsion. The 
double emulsion was poured into 1000ml 10% PVA solution and was churned up at 
100rpm/min over night holding at 40  on a magnetic force blender, and was ℃
centrifugated at 3000g for 10min. The microbubbles sediments were washed 3 times 
with distilled water after collected, and then were dried in vacuum refrigerant drier. 
By this method, the size distribution of the microbubbles was showed. 19.5% of the 
microbubbles were nearby peak 1 with the mean diameter of 238.1nm,and 34.3% of 
the microbubbles were nearby peak 2 of 1.713μm,and 46.2% of the microbubbles 
were nearby peak 3 of 3.961μm, and no microbubbles’ diameters were bigger than 
7μm. 
(2) We got the better preparation process and parameters by ultrasonic emulsion 
method with SPG membrane emulsification technique: 1ml inner aqueous phase (W1) 
was injected into 10ml outer oil phase (O) which contained 0.025g/ml PDLLA and 
1.0％Span80 insonated by ultrasonic (80W•10S•10times), we got W1/O emulsion. 
The W1/O emulsion was poured into the pressure cabin of SPG microporous 
membrane emulsifier. There was fixed a SPG membrane of 1.1μm diameter. 
Appropriate and equal 50kpa gas pressure was given by high purified N2 to press the 
W1/O emulsion through SPG microporous membrane into circularly flowing 1% PVA 
solution, and we got W1/O/W2 double emulsion. The W1/O/W2 double emulsion was 















and was centrifugated at 3000g for 10min. The microbubbles sediments were washed 
3 times with distilled water after collected, and then were dried in vacuum refrigerant 
drier. By this method, the size distribution of the microbubbles was showed. 93.6% of 
the microbubbles were nearby peak 1 with the mean diameter of 4.124μm. 6.4% of 
the microbubbles were nearby peak 2 with the mean diameter of 274nm. So we got 
better uniform-sized microbubbles by this method than by ultrasonic W/O/W double 
emulsion method. 
2. Based on the better preparation process and parameters by ultrasonic emulsion 
method with SPG membrane emulsification technique, we studied the preparation of 
HCPT-PLA microbubbles UCA for drug delivery. We used different concentrations 
of HCPT and NaOH solutions as inner aqueous phase (W1), 1.0%PVA and pH6.0 HCl 
solutions as outer aqueous phase (O). We studied the effects of drug loading and 
encapsulation efficiency with different concentrations of inner aqueous phase (W1). In 
result, there was the maximum encapsulation efficiency 66.48% when the 
concentration of inner aqueous phase (W1) was 4mg/ml and there was the maximum 
drug loading efficiency 1.084%. The SEM photos showed that the mean diameter of 
HCPT-PLA microbubbles UCA was about 5μm, and spherical shapes were formed, 
we got better uniform-sized microbubbles. 
3. In the condition of 100rpm/min, 37℃ permanent temperature, HCPT-PLA 
microbubbles UCA were vibrant a week, the drug release experiments in vitro showed 
that the percentage of cumulative drug released was 64.14%. HCPT-PLA 
microbubbles UCA were insonated by ultrasonic (3.5MHz，MI1.0, 90s/per time×3) in 
vitro, and the percentage of cumulative drug released was 94.37%. Almost drug was 
released.  
4. The drug release experiments in vivo using New Zealand big rabbits as animal 
model showed there was higher blood drug concentration using HCPT-PLA 
microbubbles UCA than only HCPT by the same dosage. At the same time, there was 
higher blood drug concentration using HCPT-PLA microbubbles UCA for a longer 
time and better controlled-release effect. 















showed that the anti-H22 cell tumor effect of HCPT-PLA microbubbles UCA with 
ultrasonic irradiation was better. 
6. The ultrasonic autoradiography experiments in vivo using New Zealand big 
rabbits as animal model showed the better heart autoradiography of the rabbit with 
HCPT-PLA microbubbles UCA, and the dosage was 20mg.Both of left and right 
cardiac ventricle showed better ultrasonic autoradiography. It showed that HCPT-PLA 
microbubbles UCA passed through lung circulation and was good uniform-sized. 
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Fig 1.1 Schematic diagram of drug concentration changes in blood after taking 
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单克隆抗体等制剂；第五代是脉冲式药物运释系统(pulsed/pulsatile drug delivery 
systems, PDDS)，是根据接收的反馈信息自动调节释放药量的自调式给药系统
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